Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.7808
-0.0823 (-9.54%)
At close: Mar 27, 2026, 4:00 PM EDT
0.7900
+0.0092 (1.18%)
After-hours: Mar 27, 2026, 7:36 PM EDT

Werewolf Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
57.05111134.34129.32157.53
Cash & Short-Term Investments
57.05111134.34129.32157.53
Cash Growth
-48.60%-17.38%3.89%-17.91%70.17%
Other Receivables
--1.356.93-
Total Trade Receivables
--1.356.93-
Other Current Assets
1.542.072.683.963.54
Total Current Assets
58.59113.07138.37140.2161.07
Net Property, Plant & Equipment
9.912.3214.8517.4516.33
Other Long-Term Assets
0.911.5421.622.591.86
Total Assets
69.4126.93174.83160.25179.25
Accounts Payable
0.753.041.341.222.04
Accrued Expenses
5.4110.598.8614.158.77
Current Portion of Long-Term Debt
28.24-6.67--
Current Portion of Leases
1.751.561.612.081.07
Unearned Revenue
--0.916.53-
Total Current Liabilities
36.1515.1819.3823.9911.87
Long-Term Debt
-26.132.66--
Long-Term Leases
7.689.4410.9912.614.59
Other Long-Term Liabilities
0.762.830.431.32-
Total Long-Term Liabilities
8.4438.3644.0813.9214.59
Total Liabilities
44.5953.5463.4637.9126.46
Common Stock
0.010.01000
Additional Paid-in Capital
500.21487.97455.44429.04405.68
Retained Earnings
-475.41-414.59-344.07-306.71-252.9
Total Common Shareholders' Equity
24.8173.39111.37122.34152.79
Shareholders' Equity
24.8173.39111.37122.34152.79
Total Liabilities & Equity
69.4126.93174.83160.25179.25
Total Debt
37.6737.0951.9214.6815.66
Net Cash (Debt)
19.3873.9182.42114.63141.87
Net Cash Growth
-73.78%-10.33%-28.10%-19.20%57.58%
Net Cash Per Share
0.411.692.313.977.69
Book Value
24.8173.39111.37122.34152.79
Book Value Per Share
0.531.673.124.248.28
Tangible Book Value
24.8173.39111.37122.34152.79
Tangible Book Value Per Share
0.531.673.124.248.28
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q